{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:33:30Z","timestamp":1778902410317,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd007245.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T00:00:00Z","timestamp":1449619200000}}],"reference-count":19,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007245.pub3","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T01:13:39Z","timestamp":1449710019000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen"],"prefix":"10.1002","author":[{"given":"Sally","family":"Dominick","sequence":"first","affiliation":[{"name":"University of California, San Diego; Moores UCSD Cancer Center; La Jolla California USA 92093"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Hickey","sequence":"additional","affiliation":[{"name":"The Royal Women's Hospital; The University of Melbourne; Level 7, Research Precinct Melbourne Victoria Australia Parkville 3052"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Chin","sequence":"additional","affiliation":[{"name":"King Edward Memorial Hospital\/SJOG Murdoch Hospital; Perth WA Australia WA6008"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Irene","family":"Su","sequence":"additional","affiliation":[{"name":"University of California, San Diego; Department of Reproductive Medicine; La Jolla California USA 92093"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD007245.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1510-5","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen treated women","volume":"114","author":"Chan","year":"2007","journal-title":"BJOG"},{"issue":"5","key":"10.1002\/14651858.CD007245.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0b013e31828bf80c","article-title":"Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial","volume":"121","author":"Wong","year":"2013","journal-title":"Obstetrics and Gynecology"},{"issue":"9243","key":"10.1002\/14651858.CD007245.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2009.06.014","article-title":"Prevention of tamoxifen induced endometrial polyps using levonorgestrel releasing intrauterine system: Long-term follow-up of a randomised control trial","volume":"114","author":"Gardner","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13697130802163168","article-title":"Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen","volume":"11","author":"Kesim","year":"2008","journal-title":"Climacteric"},{"issue":"1","key":"10.1002\/14651858.CD007245.pub3-BIB0006|cit6","first-page":"327","article-title":"The use of levonorgestrel-releasing intrauterine system in prevention of endometrial pathology in women with breast cancer treated with tamoxifen","volume":"3","author":"Omar","year":"2010","journal-title":"The International Journal of Medicine"},{"key":"10.1002\/14651858.CD007245.pub3-BIB0007|cit7","first-page":"1475","article-title":"Tamoxifen and uterine cancer","volume":"107(6)","author":"ACOG Committee Opinion No 336","year":"2006","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD007245.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"10;25","author":"Coates","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007245.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecologic Oncology"},{"issue":"9869","key":"10.1002\/14651858.CD007245.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"9472","key":"10.1002\/14651858.CD007245.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists Collaborative Group (EBCTCG)","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007245.pub3-BIB0012|cit12","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007245.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007245.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.24738","article-title":"A cases control study on hormone therapy as a risk factor for breast cancer in Finland","volume":"126","author":"Lyytinen","year":"July 2009","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD007245.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0015-0282(16)37382-4","article-title":"Intrauterine administration of progesterone by a slow releasing device","volume":"21","author":"Scommegna","year":"1970","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD007245.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD007245.pub3-BIB0017|cit17","first-page":"1318","article-title":"Risk of endometrial cancer after tamoxifen treatment of breast cancer","volume":"343","author":"Leeuwen","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007245.pub3-BIB0018|cit18","unstructured":"American Cancer Society www.cancer.org www.cancer.org 2008"},{"key":"10.1002\/14651858.CD007245.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","article-title":"Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device","volume":"41(4)","author":"Xiao","year":"1990","journal-title":"Contraception"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007245.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007245.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:08:32Z","timestamp":1628546912000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007245.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007245.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007245.pub4","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,9]]}}}